The Health Expert Committee of the National Command and Operation Centre (NCOC) has approved the Sinopharm and Sinovac vaccines for administration to children aged above 12 starting November 15.
The NCOC, in a tweet, said the Chinese jabs will be available in addition to the Pfizer vaccine for children above 12 years of age.